Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MediWound Ltd. - Ordinary Shares (NQ:MDWD)

18.95 -0.36 (-1.84%)
Streaming Delayed Price Updated: 10:39 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,497
Open 19.25
Bid (Size) 18.86 (200)
Ask (Size) 19.03 (100)
Prev. Close 19.30
Today's Range 18.71 - 19.30
52wk Range 14.14 - 22.50
Shares Outstanding 27,272,818
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Ltd (NASDAQ:MDWD) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates ↗
MediWound's Q3 2025 results show revenue miss but a smaller-than-expected loss. The company advances its EscharEx pipeline and expands NexoBrid manufacturing. 
Via Chartmill

Performance

YTD
+2.9%
+2.9%
1 Month
+2.6%
+2.6%
3 Month
+5.8%
+5.8%
6 Month
-10.2%
-10.2%
1 Year
+18.3%
+18.3%

More News

Read More
News headline image
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
From MediWound Ltd.
Via GlobeNewswire
News headline image
Examining the Future: MediWound's Earnings Outlook ↗
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
Via Benzinga
News headline image
Earnings Outlook For MediWound ↗
Via Benzinga
News headline image
Earnings Scheduled For November 20, 2025 ↗
Via Benzinga
News headline image
MediWound to Report Third Quarter 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Expands Global Reach with Marketing Approval of NexoBrid® in Australia
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Revenue Jumps 43% in Q2 ↗
Via The Motley Fool
News headline image
MediWound (MDWD) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
MediWound Ltd (NASDAQ:MDWD) Reports Mixed Q2 2025 Results with Revenue Growth but Wider-Than-Expected Losses ↗
Via Chartmill
News headline image
MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound Announces New EscharEx® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report Second Quarter 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire
News headline image
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
MediWound (MDWD) Q1 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update
From MediWound Ltd.
Via GlobeNewswire
News headline image
Earnings Scheduled For May 21, 2025 ↗
Via Benzinga
News headline image
MediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers
From MediWound Ltd.
Via GlobeNewswire
News headline image
MediWound to Report First Quarter 2025 Financial Results
From MediWound Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is MediWound Ltd. - Ordinary Shares publicly traded?
Yes, MediWound Ltd. - Ordinary Shares is publicly traded.
What exchange does MediWound Ltd. - Ordinary Shares trade on?
MediWound Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MediWound Ltd. - Ordinary Shares?
The ticker symbol for MediWound Ltd. - Ordinary Shares is MDWD on the Nasdaq Stock Market
What is the current price of MediWound Ltd. - Ordinary Shares?
The current price of MediWound Ltd. - Ordinary Shares is 18.95
When was MediWound Ltd. - Ordinary Shares last traded?
The last trade of MediWound Ltd. - Ordinary Shares was at 01/09/26 10:39 AM ET
What is the market capitalization of MediWound Ltd. - Ordinary Shares?
The market capitalization of MediWound Ltd. - Ordinary Shares is 516.68M
How many shares of MediWound Ltd. - Ordinary Shares are outstanding?
MediWound Ltd. - Ordinary Shares has 517M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.